ArticleAtherosclerosis plus2021

Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study.

Marina Blanco-Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.